The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids
2016/11/24 by Aedín Cassidy, Anne-Marie Minihane, Anne Marie Minihane · 27 citations
Medicine · #Phytochemicals and Antioxidant Activities #Tea Polyphenols and Effects #Natural Antidiabetic Agents Studies
paper · pdf · doi:10.3945/ajcn.116.136051
Abstract
At a population level, there is growing evidence of the beneficial effects of dietary flavonoids on health. However, there is extensive heterogeneity in the response to increased intake, which is likely mediated via wide interindividual variability in flavonoid absorption and metabolism. Flavonoids are extensively metabolized by phase I and phase II metabolism (which occur predominantly in the gastrointestinal tract and liver) and colonic microbial metabolism. A number of factors, including age, sex, and genotype, may affect these metabolic processes. In addition, food composition and flavonoid source are likely to affect bioavailability, and emerging data suggest a critical role for the microbiome. This review will focus on the current knowledge for the main subclasses of flavonoids, including anthocyanins, flavonols, flavan-3-ols, and flavanones, for which there is growing evidence from prospective studies of beneficial effects on health. The identification of key factors that govern metabolism and an understanding of how the differential capacity to metabolize these bioactive compounds affect health outcomes will help establish how to optimize intakes of flavonoids for health benefits and in specific subgroups. We identify research areas that need to be addressed to further understand important determinants of flavonoid bioavailability and metabolism and to advance the knowledge base that is required to move toward the development of dietary guidelines and recommendations for flavonoids and flavonoid-rich foods.
Cited by
- Flavonoids and the gastrointestinal tract: Local and systemic effects
- Short-term feeding of defatted bovine colostrum mitigates inflammation in the gut via changes in metabolites and microbiota in a chicken animal model
- Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome. [europepmc]
- Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways. [europepmc]
- Sulphated Flavonoids: Biosynthesis, Structures, and Biological Activities. [europepmc]
- Flavonoids in Cancer and Apoptosis. [europepmc]
- Role of Intestinal Microbiota in the Bioavailability and Physiological Functions of Dietary Polyphenols. [europepmc]
- Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trial. [europepmc]
- The path toward using microbial metabolites as therapies. [europepmc]
- Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions. [europepmc]
- Recent Research on the Health Benefits of Blueberries and Their Anthocyanins. [europepmc]
- Perspective: Dietary Biomarkers of Intake and Exposure-Exploration with Omics Approaches. [europepmc]
- Flavonoid intake is associated with lower mortality in the Danish Diet Cancer and Health Cohort. [europepmc]
- Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial. [europepmc]
- Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans. [europepmc]
- The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases. [europepmc]
- Anti-Fungal Efficacy and Mechanisms of Flavonoids. [europepmc]
- Flavonoids as Anticancer Agents. [europepmc]
- Flavonoids in Cancer Metastasis. [europepmc]
- Bioavailability of Micronutrients From Nutrient-Dense Whole Foods: Zooming in on Dairy, Vegetables, and Fruits. [europepmc]
- Flavonoid Nanoparticles: A Promising Approach for Cancer Therapy. [europepmc]
- Edible Plant Oil: Global Status, Health Issues, and Perspectives. [europepmc]
- Revisiting the Oxidation of Flavonoids: Loss, Conservation or Enhancement of Their Antioxidant Properties. [europepmc]
- Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms. [europepmc]
- Kaempferol: Antimicrobial Properties, Sources, Clinical, and Traditional Applications. [europepmc]
- The Interaction between Flavonoids and Intestinal Microbes: A Review. [europepmc]
- Flavonoids: Overview of Biosynthesis, Biological Activity, and Current Extraction Techniques. [europepmc]
Related